COWARD D SCOTT — SEC insider filings

SEC reporting owner CIK 1247296. 29 insider filings on record with FilingPulse; latest filed 2026-10-07.

Transaction summary — filings shown

Covers all 29 filings on record, filed 2021-02-18 to 2026-10-07. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
EXACT SCIENCES CORP (EXAS)Director27—21 legs · 70,477 sh · $8,098,90654
Humacyte, Inc. (HUMA)Director2——1

Insider filings — COWARD D SCOTT

FiledFormIssuerReported transactionsSource
2026-10-074Humacyte, Inc. (HUMA)Grant/award (A): 125,000 (derivative) @ $0EDGAR
2026-09-283Humacyte, Inc. (HUMA)Holdings only — no transactions reportedEDGAR
2026-03-234EXACT SCIENCES CORP (EXAS)Disposition to issuer (D): 52,164 · Disposition to issuer (D): 5,398 · Disposition to issuer (D): 4,694 · Disposition to issuer (D): 4,175 (derivative) · Disposition to issuer (D): 10,786 (derivative) · Disposition to issuer (D): 12,875 (derivative)EDGAR
2025-06-164EXACT SCIENCES CORP (EXAS)Grant/award (A): 5,398 @ $0EDGAR
2025-02-214EXACT SCIENCES CORP (EXAS)Option exercise (M): 2,248 @ $0 · Tax withholding (F): 667 @ $49.63 · Option exercise (M): 2,248 (derivative) @ $0EDGAR
2024-12-204/AEXACT SCIENCES CORP (EXAS)Grant/award (A): 5,939 @ $0EDGAR
2024-06-174EXACT SCIENCES CORP (EXAS)Grant/award (A): 5,444 @ $0EDGAR
2024-05-024EXACT SCIENCES CORP (EXAS)Grant/award (A): 218 @ $0 · Sale (S): 67 @ $60.15EDGAR
2024-02-234EXACT SCIENCES CORP (EXAS)Grant/award (A): 2,034 @ $0 · Sale (S): 663 @ $59.78EDGAR
2024-02-224EXACT SCIENCES CORP (EXAS)Option exercise (M): 2,248 @ $0 · Sale (S): 706 @ $61.50 · Option exercise (M): 2,248 (derivative) @ $0EDGAR
2024-02-164EXACT SCIENCES CORP (EXAS)Option exercise (M): 3,972 @ $0 · Sale (S): 1,376 @ $61.43 · Option exercise (M): 3,972 (derivative) @ $0EDGAR
2023-06-124EXACT SCIENCES CORP (EXAS)Grant/award (A): 6,209 @ $0EDGAR
2023-03-014EXACT SCIENCES CORP (EXAS)Option exercise (M): 5,931 @ $0 · Option exercise (M): 3,263 @ $0 · Sale (S): 4,153 @ $61.12 · Option exercise (M): 5,931 (derivative) @ $0 · Option exercise (M): 3,263 (derivative) @ $0EDGAR
2023-02-234EXACT SCIENCES CORP (EXAS)Option exercise (M): 2,248 @ $0 · Sale (S): 1,007 @ $62.72 · Option exercise (M): 2,248 (derivative) @ $0EDGAR
2023-02-164EXACT SCIENCES CORP (EXAS)Option exercise (M): 3,972 @ $0 · Sale (S): 1,821 @ $65.59 · Option exercise (M): 3,972 (derivative) @ $0EDGAR
2023-01-054EXACT SCIENCES CORP (EXAS)Grant/award (A): 328 @ $47.41 · Grant/award (A): 7,780 @ $0EDGAR
2022-03-024EXACT SCIENCES CORP (EXAS)Option exercise (M): 5,025 @ $0 · Option exercise (M): 3,263 @ $0 · Sale (S): 3,912 @ $76.69 · Option exercise (M): 5,025 (derivative) @ $0 · Option exercise (M): 3,263 (derivative) @ $0EDGAR
2022-03-014EXACT SCIENCES CORP (EXAS)Grant/award (A): 5,931 (derivative) @ $0EDGAR
2022-02-254EXACT SCIENCES CORP (EXAS)Option exercise (M): 12,747 @ $0 · Sale (S): 5,815 @ $70.10 · Option exercise (M): 12,747 (derivative) @ $0EDGAR
2022-02-244EXACT SCIENCES CORP (EXAS)Option exercise (M): 2,247 @ $0 · Sale (S): 1,109 @ $69.05 · Option exercise (M): 2,247 (derivative) @ $0EDGAR
2022-02-164EXACT SCIENCES CORP (EXAS)Grant/award (A): 328 @ $64.74 · Option exercise (M): 3,972 @ $78.33 · Sale (S): 1,813 @ $79.55 · Option exercise (M): 3,972 (derivative) @ $0EDGAR
2021-03-054EXACT SCIENCES CORP (EXAS)Sale (S): 2,664 @ $135.02EDGAR
2021-03-034EXACT SCIENCES CORP (EXAS)Option exercise (M): 5,025 @ $0 · Sale (S): 2,361 @ $138.42 · Sale (S): 1,765 @ $140.31 · Option exercise (M): 5,025 (derivative) @ $0EDGAR
2021-03-024EXACT SCIENCES CORP (EXAS)Option exercise (M): 3,263 @ $0 · Sale (S): 1,498 @ $137.44 · Option exercise (M): 4,175 @ $44.37 · Sale (S): 4,175 @ $136.79 · Option exercise (M): 3,263 (derivative) @ $0 · Option exercise (M): 4,175 (derivative) @ $0EDGAR
2021-03-014EXACT SCIENCES CORP (EXAS)Sale (S): 6,788 @ $132.96EDGAR
2021-02-254EXACT SCIENCES CORP (EXAS)Option exercise (M): 12,850 @ $0 · Option exercise (M): 18,750 @ $21.68 · Sale (S): 18,750 @ $136.51 · Sale (S): 6,062 @ $136.30 · Option exercise (M): 12,850 (derivative) @ $0 · Option exercise (M): 18,750 (derivative) @ $0EDGAR
2021-02-234EXACT SCIENCES CORP (EXAS)Grant/award (A): 8,991 (derivative) @ $0EDGAR
2021-02-224EXACT SCIENCES CORP (EXAS)Sale (S): 1,980 @ $140.79EDGAR
2021-02-184EXACT SCIENCES CORP (EXAS)Option exercise (M): 3,972 @ $0 · Sale (S): 1,992 @ $142.66 · Option exercise (M): 3,972 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-02-16 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1247296 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs